Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease

Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease

Lin Chen,1,* Xiujuan Zhang,2,* Li Zhang,3 Dongmei Zheng2 1Department of Breast and Thyroid Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People’s Republic of China; 2Department of Endocrinology, Shandong Provincial Hospital Affili...

Full description

Bibliographic Details
Main Authors: Chen L, Zhang X, Zhang L, Zheng D
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:
dipeptidyl peptidase 4 inhibitor
non-alcoholic fatty liver disease
inflammation
insulin resistance
Online Access:https://www.dovepress.com/effect-of-saxagliptin-a-dipeptidyl-peptidase-4-inhibitor-on-non-alcoho-peer-reviewed-article-DMSO

Internet

https://www.dovepress.com/effect-of-saxagliptin-a-dipeptidyl-peptidase-4-inhibitor-on-non-alcoho-peer-reviewed-article-DMSO

Similar Items